Home›Trial›NCT07114874
🔬NCT07114874Phase 3RECRUITING

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Study Summary

This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.

Conditions
Schizophrenia
Interventions / Drugs
NBI-1117568
View on ClinicalTrials.gov ↗
Sponsor
NBIX
Neurocrine Biosciences
Neuroscience
D50/100
Study Details
Enrollment800 participants
Primary Completion—
Lead SponsorNeurocrine Biosciences
Data Retrieved2026-04-11 04:22:17.614564+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.